Notice/News
Notice/News
The external news articles in this bulletin have been collected and published solely for the purpose of providing information and may differ from our official position. We make no guarantee of the accuracy, timeliness, or completeness of the content of the article and are not liable for any direct or indirect damage that may occur.
Notice
[edaily] “ToolGen’s Yoo Jong‑sang Says CRISPR‑Cas9 Patent Battle Heats Up in H2, With Rising Pressure for a Three‑Party Deal”
주식회사 툴젠
|2026.03.26
이데일리에 당사 기사가 게재되었습니다.
자세한 내용은 아래 링크에서 확인하실 수 있습니다.